Evidence map›Paper›PMID 22498744›Full record

ArticleBlood2012

Heme-regulated eIF2α kinase activated Atf4 signaling pathway in oxidative stress and erythropoiesis.

Rajasekhar N V S Suragani, Roshini S Zachariah, Jason G Velazquez, Sijin Liu, Chiao-Wang Sun, Tim M Townes, Jane-Jane Chen

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 100 papers.

0numbers the graph read from it
0cells of the map it votes in
100citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

100 citing papers in PubMed, 161 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

40 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Rajasekhar N V S SuraganiHarvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Roshini S Zachariah
Jason G Velazquez
Sijin Liu
Chiao-Wang Sun
Tim M Townes
Jane-Jane Chen
Harvard–MIT Division of Health Sciences and Technology · USUniversity of Alabama at Birmingham · USMassachusetts Institute of Technology · US

Funding

REGULATION OF PROTEIN SYNTHESIS AND ERYTHROPOIESISR01DK016272 · NIDDK · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI CHEN, JANE-JANE · 1986 to 2007
$2.3M
HRI-eIF2a Phosphorylation Signaling in Oxidative Stress and ErythropoiesisR01DK087984 · NIDDK · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI CHEN, JANE-JANE · 2010 to 2017
$2.1M
HRI/elF2aP Signaling Pathway as Potential Pharmaceutical Targets for ThalassemiaR21DK078442 · NIDDK · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI CHEN, JANE-JANE · 2008 to 2010
$561k
HRI-eIF2a Phosphorylation signaling in oxidative stress and erythropoiesisR56DK087984 · NIDDK · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI CHEN, JANE-JANE · 2013 to 2013
$78k
NIDDK NIH HHS DK78442NIDDK NIH HHS DK 87984NIDDK NIH HHS R01 DK016272NIDDK NIH HHS R01 DK087984NIDDK NIH HHS R21 DK078442NIDDK NIH HHS R56 DK087984
6 · The paper itself

Abstract

Heme-regulated eIF2α kinase (Hri) is necessary for balanced synthesis of heme and globin. In addition, Hri deficiency exacerbates the phenotypic severity of β-thalassemia intermedia in mice. Activation of Hri during heme deficiency and in β-thalassemia increases eIF2α phosphorylation and inhibits globin translation. Under endoplasmic reticulum stress and nutrient starvation, eIF2α phosphorylation also induces the Atf4 signaling pathway to mitigate stress. Although the function of Hri in regulating globin translation is well established, its role in Atf4 signaling in erythroid precursors is not known. Here, we report the role of the Hri-activated Atf4 signaling pathway in reducing oxidative stress and in promoting erythroid differentiation during erythropoiesis. On acute oxidative stress, Hri(-/-) erythroblasts suffered from increased levels of reactive oxygen species (ROS) and apoptosis. During chronic iron deficiency in vivo, Hri is necessary both to reduce oxidative stress and to promote erythroid differentiation. Hri(-/-) mice developed ineffective erythropoiesis during iron deficiency with inhibition of differentiation at the basophilic erythroblast stage. This inhibition is recapitulated during ex vivo differentiation of Hri(-/-) fetal liver erythroid progenitors. Importantly, the Hri-eIF2αP-Atf4 pathway was activated and required for erythroid differentiation. We further demonstrate the potential of modulating Hri-eIF2αP-Atf4 signaling with chemical compounds as pharmaceutical therapies for β-thalassemia.

Indexed as

ErythropoiesisOxidative StressSignal TransductionActivating Transcription Factor 4Animalsbeta-ThalassemiaCell DifferentiationCells, CulturedeIF-2 KinaseErythroblastsFetusGlobinsIronIron DeficienciesLiverMiceActivating Transcription Factor 4Atf4 protein, mouseeIF-2 KinaseGlobinsIronReactive Oxygen Species

Identifiers

PMID22498744
PMCPMC3369616
OpenAlexW2019425923

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.